Dr. Markoski leads national strategies to strengthen medication access, mitigate drug shortages and enhance supply chain resilience for U.S. healthcare systems. He co-founded the End Drug Shortages Alliance, now with 300-plus members and 80-plus organizations, and established its rapid response team, the only cross-industry group providing real-time quantified insights and guidance during major pharmaceutical disruptions such as the Akorn closure, Pfizer Rocky Mount plant damage and Hurricane Helene IV shortages. His predictive analytics work identified that 8,300 patients annually go untreated for Bacillus Calmette-Guérin due to supply constraints, prompting national awareness and policy engagement. As lead author of Vizient’s 2024 Beyond the Shortage report, he quantified $900 million in annual labor costs and 20 million labor hours tied to shortage management, influencing advocacy and reform efforts. Dr. Markoski’s proactive interventions have prevented cascading shortages and improved provider preparedness, while his mentorship as Vizient’s intern and residency coordinator is shaping the next generation of pharmacy supply chain leaders. A sought-after national speaker and industry thought leader, he continues to set new benchmarks for crisis response, predictive modeling and long-term supply chain strategy in healthcare.
